Related Experiment Video
Updated: Jul 8, 2026

Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Published on: November 21, 2011
Reactive oxygen and nitrogen species in the course of B-CLL
E Jabłońska1, B Kiersnowska-Rogowska, W Ratajczak
1Department of Immunology, Medical University of Białystok, ul. Waszyngtona 15A, 15-274 Białystok, Poland. ewaj@amb.edu.pl
Purpose:
The study objective was to investigate the production of NO, cGMP and superoxide anion radical by neutrophils, and to examine alterations in serum or plasma total nitric oxide, MDA and cGMP levels in B-CLL patients.
Material And Methods:
PMNs were isolated from 20 patients with B-CLL. Total nitrite was measured in cell supernatants and serum by Griess method. The generation of superoxide anion radical by cells was estimated using cytochrom-c reduction test. The cGMP level in cell supernatants and plasma was assessed by ELISA kit whereas serum MDA level using a spectrophotometric assay by Guege and Aus.
Results:
The PMNs in B-CLL patients were characterised by impaired NO generation and enhanced cGMP production. Contrary to the control group, no significant effect was found of rhlL-15 and rhIL-18 on the release of these mediators by PMNs. Superoxide anion radical release by PMNs was decrease. Serum MDA and plasma cGMP levels were elevated in B-CLL patients as compared to the controls.
Conclusions:
The reduced production of nitric oxide and superoxide anion radicals by PMNs in B-CLL may impair the cytotoxic effect of neutrophils on leukaemic B cells. Low secretion of nitric oxide by PMNs and high levels of cGMP in PMN supernatants suggest that activation of guanyl cyclase (sGC) in these patients may occur in the presence of agents other than nitric oxide. Moreover, the findings indicate the enhancement of lipid peroxidation with the progression of the neoplastic process in B-CLL patients.
Related Concept Videos
Bioactivation and Tissue Toxicity
Radical Reactivity: Overview
Oxygen Requirements and Growth Patterns
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Radical Reactivity: Nucleophilic Radicals
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

